!

Baylor resumes normal business operations on Thursday, Jan. 23

Baylor College of Medicine and its clinics, closed Wednesday, Jan. 22, will reopen under normal business operations on Thursday, Jan. 23. Patient appointments will be as scheduled on Thursday.

Baylor College of Medicine

Enhancement of Biomarkers for Type 1 Diabetes (H-41091)

Description

Content

Study Goal(s): To utilize immunologic biomarkers, in particular a variant-specific IA-2 autoantibodies, for type 1 diabetes prediction

Eligibility Criteria: Individuals with type 1 diabetes 

Investigators: Massimo Pietropaolo, M.D. (principal investigator), Maria J. Redondo M.D., Ph.D. (co-investigator)

Supported by: National institutes of Health, R01 Award

IRB: H-41091

Status:

Active

Created:

Back to topback-to-top